Global Immunodermatology Market: Market Outlook
Immunodermatology is a medical specialty that focuses on diagnosing and treating skin disorders characterized by responses that affect the body's immune system. Immunodermatology testing is important in the diagnosis and treatment of many diseases affecting the epithelial organs including the skin, mucous membranes, intestines, and respiratory tract. The skin is the largest and heaviest organ in the human body. Skin diseases affect patients at any time from newborns to the elderly, and they can be temporary or chronic, painless or painful, conditional or genetic. The skin is the body's first defective organ that fights antigens on T cells and produces many types of cytokines. With the increase in the elderly, skincare may be gaining some attention.
Pores and skin conditions are very different health problems among many people across the country, together they exceed the magnitude of conditions including obesity, high blood pressure, and disease. The increase in immunodermatology market size will be attributed to several factors including the number of older people, increased disposal income, increased health insurance, and the growing need for early diagnosis of skin conditions.
What are the Key Trends Impacting Growth of the Immunodermatology Market?
More than 80 percent of the world's population is affected by skin disorders with varying degrees of symptoms and severity. Among all the immunodermatological infections that occur such as atopic dermatitis is a frequent spread of inflamed skin that can affect patients of all ages and is the result of a complex combination of natural, immunological, genetic, and pharmacologic conditions. It has been observed in recent years that the pool of patients affected by skin conditions has grown significantly due to factors such as malnutrition, unhealthy eating habits, increased stress, pollution, and a lack of self-defense in human society. With this increased demand for effective therapies and dermatological drugs for treating skin conditions, the immunodermatology market will rise at a significant CAGR in the forecast period.
Although effective treatments are available for common skin conditions, immunodermatology drugs are popular because of their inexpensive nature and readily available in all regional markets. The immunodermatology market is likely to see a healthy growth path in the next few years as well, thanks to an increase in patients about available courses for the treatment of skin conditions and spending money on skin products.
The Unstoppable Rise of Immunodermatology
- How a Fringe Movement Went Mainstream
According to DALYs 2013, Skin Diseases accounted for 1.79% of the world's disease burden. Dermatitis is one of the most common diseases in humans. It is widespread in all cultures, occurs in all ages, and affects between 30% and 70% of the population, with very high rates of people at risk. Dermatitis costs the health care system US $ 75 billion in medical, preventive, and drug-free, non-pharmacological costs. Atopic dermatitis, one of the most common immunodermatology disease, is a recurring skin disease. The rate of atopic dermatitis has increased by 2 to 3 in industrialized countries, affecting about 15% to 20% of children and 1% to 3% of adults worldwide. It has a significant impact on the quality of life of a patient and cost approximately $ 37.7 billion of expenditure on treatment. Atopic dermatitis has been the most common immunodermatological disease in all ages accounting for 31.5% of the total. Its prevalence ranges from 1.2% in Asia to 17.1% in Europe in adults, and 0.96% in children 22.6% in Asia.
Psoriasis is another incurable and inflammatory immunodermatological disease of the skin and joints affecting 1% to 3% of the population. Cutaneous manifestations are common in primary immune deficiency diseases, affecting between 40% and 70% of patients diagnosed with a major immunnodermatology defect. Vitiligo is another major immunodermatological disease. The prevalence of vitiligo is between 0.4% and 2.1% of the world's population. The prevalence of vitiligo in the USA is close to 1%. According to a 2017 report, the epidemiology of alopecia areata was 5.8% and psoriasis was 2.6%.
What are the Key Challenges that may Restrain Growth of the Immunodermatology Market?
Recall of the products of these drugs is expected to prevent the use of skin drugs and is expected to slow down the growth of the immunodermatology market in the predicted period.
Key Segments of Immunodermatology Market Covered in the Report:
Based on Type, the Immunodermatology market has been segmented as
- Systemic sclerosis
- Alopecia areata
- Lichen sclerosus
- Allergic Dermatitis
- Atopic Dermatitis
- Lupus erythematosus
- Blistering diseases
- Connective tissue diseases
Based on Diagnosis, the Immunodermatology market has been segmented as
- Immunofluorescence Testing
- Blood Test
Based on Therapy, the Immunodermatology market has been segmented as
- Drug Therapy
- Calcineurin Inhibitors
- TNF Alfa Inhibitors
- Interleukin Inhibitors
- Intensed Pulsed Light (IPL)Therapy
- Stem Cell Therapy
- Gene Therapy
Based on the mode of administration, the Immunodermatology market has been segmented as
Based on the region, the Immunodermatology market has been segmented as
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
Key players such as
- Valeant Pharmaceuticals
- Bausch Health
- Glenmark Pharmaceuticals Inc.
- Astellas Pharma
- Novopharm Limited
- Aspen Pharmacare Inc.
- Prometheus Laboratories
- Taro Pharmaceuticals Inc.
- Nucare Pharmaceuticals Inc.
- others are actively involved in offering Immunodermatology for different applications.
What Strategies are the Key Players Adopting for Increasing their Market Share in the Immunodermatology Market?
Key players involved in the Immunodermatology market are using strategies such as mergers and acquisitions, partnerships, and introducing new products to strengthen their position in the cost-effective immunodermatology market. They are continuously investing in R&D and new product launches of products with better results with cost-effectiveness.
Mergers and acquisitions have been majorly adopted and have shown great success to the key players in the expansion of immunodermatology market share. Rising healthcare industry in major countries in Asia will give a decent opportunity for the key players to expand the market share
What are the Key Opportunities for Immunodermatology Manufacturers?
A variety of diseases often break out in clinical and histological presentation and, although the diseases themselves are rare, they can also bring about the symptoms of immunodermatological disease. Therefore, the diagnosis of immunodermatological disease is often delayed. Several areas have specialized attention, such as photo-immunology, inflammatory diseases, allergen contact dermatitis, and atopic eczema, possibly autoimmune skin diseases such as vitiligo and psoriasis, and eventually immunodermatology diseases. These requirements will ignite the immunodermatology diagnosis market. The growing value of early detection is a fundamental element of the perfect contrasting drive for the skin and will fuel the immunodermatology diagnosis market.
The immunodermatology market will attest to the unmistakable development driven by the biologics segment. Along with the growing demand for effective skin treatment, the increase in the number of companies investing in the market, the dramatic increase in the number of classes of drugs available, and the significant level of research and development have helped the global immunodermatology market.
Although effective treatments are available for common skin conditions, immunodermatology drugs are popular because of their inexpensive nature and readily available in all regional markets. Advanced drugs play an important role in the treatment of dermatologic diseases. Topical pharmaceutical drugs account for a large percentage of the products in the immunodermatology market. With the increase in the elderly, skincare may be gaining some attention. As people get older, the risk of developing skin-related disorders increases, due to factors, such as changes in connective tissue, a decrease in skin strength and firmness, and a reduction in secretions from the dominant glands. The increase in skin diseases and the increasing rates of advanced disease-related illnesses, etiology, and available treatments are leading to higher growth in skin treatments leading to growth in the immunodermatology market.
Regional share of Sales of Immunodermatology
North America is expected to lead the world immunodermatology market. Increased spending on health care, skin disease awareness, and the strong presence of pharmaceutical companies are expected to drive immunodermatology market growth in North America. The U.S., followed by a route to Canada, is the largest commercial center for immunodermatology medicine. North America and Europe are the leading markets, due to the growing size of pores and skin diseases and increasing concentration around the borders of dozens of immunodermatology cases within the regions. The UK, Germany, and France are centralized nations that maintain a certain level within the EU trade center.
The Asian commercial center is developing at great cost, increasing immunodermatology diseases, the increase of more elderly people, and the increasing use of immunodermatological medical services in that area. Referrals made through various government partnerships to increase focus on immunodermatological services and its management also contribute to the development of the Asian Dermatology Center in reducing the commercial center. Global destinations, including India, Japan, and China are the main immunodermatology markets within the region. According to another RNCOS test report, Asia has been seeing a better explosion in healthy skincare products falling across the globe, backed up by factors associated with the development of corrective strategies and skin provides for the majority of Asians. In the next few years, the immunodermatology market in the Asia Pacific and around the World is likely to emerge as the most promising markets for skin care products due to the high incidence of cases such as acne and psoriasis. Other factors, such as a growing willingness to adopt high-quality and cost-effective treatments, growing investment in the manufacturing sector, and increased awareness of skin conditions and potential treatments among the population are fuelling the immunodermatology market. In the Asia-Pacific, an ever-increasing pool of patient numbers, raising awareness, and disposable earnings are expected to be key to strong regional market growth.
What is the Repercussion of the Pandemic on the Growth of the Immunodermatology Market?
The effect of COVID-19 on the treatment techniques of immunodermatology is small because the virus appears to not affect the skin of infected people. However, the doctor visits to the clinic have declined due to the pandemic.
Also due to the pandemic, manufacturers might not be able to purchase the ingredients like before. There are notable supply chain challenges for the Immunodermatology market. The investigations and R&D going on for immunodermatology treatment has undergone on hold due to Covid-19. But concerns related to health and the environment during the pandemic are expected to take growth again in the near short term.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.